If you're in New York and need stem cells: why fly to Medellín, Colombia to treat your joint pain

Every month we treat patients who fly to Medellín from New York. They've usually tried injections, physical therapy, opioids, or been offered joint-replacement surgery. Most don't travel because of price — they travel because in New York they can't get legal access to a serious expanded mesenchymal stem cell protocol. This guide explains why Medellín has become their preferred alternative and what the process looks like, step by step.

1. The reality of regenerative medicine in New York

New York demands a body that performs 12 hours a day for decades. Life in New York — running, spinning, boxing, tennis and skiing, constant travel and sedentary office work — is producing a generation with early osteoarthritis, chronic tendinopathies and stubborn low-back pain. Local orthopedic surgeons typically offer three paths: anti-inflammatories, cortisone injections or surgery. Expanded stem cell therapy, exosomes and peptides are still hard to access in a regulated setting.

On top of that, in New York a comparable protocol — when available — typically costs around USD 30,000–60,000, usually without follow-up included.

2. Why Medellín and not another destination

• Real distance from New York: 5h 30min. direct JFK/EWR–BOG flights on Avianca, Delta and JetBlue with immediate connection to MDE.
• Stable climate year-round (18–24 °C / 64–75 °F), ideal for post-injection recovery.
• Mature clinical ecosystem: Medellín hosts internationally accredited hospitals and GMP-grade cell therapy labs.
• Average savings of 65–75 % vs. equivalent care in New York, including consultations, cells, applications and 6-month follow-up.
• Bilingual care (Spanish–English) with door-to-door logistics coordination.
• Same time zone as Medellín most of the year, making follow-up telemedicine easy.

3. What we most often treat in patients from New York

The typical profile arriving from New York is Wall Street executives, Central Park runners, attorneys and recreational athletes from Manhattan and Brooklyn. The diagnoses we see most often:

• Knee osteoarthritis grade II–III, with or without meniscal injury, seeking an alternative to replacement surgery.
• Partial rotator cuff tears and chronic shoulder tendinopathy.
• Lumbar and cervical disc disease, contained herniations, as an alternative to spinal fusion.
• Early hip osteoarthritis, groin pain, trochanteric bursitis.
• Chronic tendinopathies (epicondylitis, Achilles, patellar) in amateur athletes.
• Systemic IV protocols for inflammation, fatigue and longevity in executives.

4. How mesenchymal stem cell therapy works

We use allogeneic mesenchymal stem cells (MSCs) from umbilical cord, processed and expanded in a GMP-grade lab. These cells don't replace tissue: they modulate inflammation, release trophic factors and promote endogenous repair of cartilage, tendon or intervertebral disc.

The protocol combines:

• Ultrasound-guided intra-articular injection performed directly by Dr. Joaqui.
• Systemic IV dose to modulate whole-body inflammation.
• Regenerative peptides (BPC-157, TB-500, CJC/Ipamorelin depending on case) to potentiate the response.
• Biomechanical rehab post-injection and personalized supplementation protocol.

5. Real costs for a patient traveling from New York

Direct references from recent patients who traveled from New York:

• Intra-articular MSC injection: from USD 4,000.
• Joint + IV + peptide protocol: USD 8,500–12,000.
• 10-day longevity program (MSC + NAD+ + peptides + exosomes): from USD 10,500.
• Typical stay at a premium medical hotel: USD 120–220/night.
• Round-trip flight from New York: variable, typically less than a single local hospital copay.

All protocols include: medical consultations, cells with lot certificate, control labs, applications, and 6 months of telemedicine follow-up.

6. Logistics: what the trip from New York looks like

1. Initial teleconsult (30–45 min) with Dr. Joaqui. We send a clinical intake form beforehand.
2. You share imaging (MRI, X-rays) and recent labs.
3. You receive a personalized plan with protocol, schedule and closed budget.
4. Our team coordinates medical hotel, transfers and translator if needed.
5. You fly to Medellín (JMC / MDE). US citizens don't need a visa for stays in Colombia under 90 days.
6. Typical stay: 5–10 days with 2–3 application sessions.
7. You fly home to New York with a written supplementation & rehab protocol and telemedicine follow-up.

7. Safety, traceability and legal aspects

Colombia regulates cell therapy through INVIMA and institutional ethics committees. Every cell lot we use includes reports on:

• Cell viability (> 90%).
• Phenotype with CD73, CD90, CD105 positive and CD34, CD45 negative markers.
• Sterility, absence of endotoxins and mycoplasma.
• Full traceability from the donor.

The patient receives copies of these reports and a complete medical record to share with their New York physician.

8. What patients from New York say

"As a 52-year-old attorney in Manhattan, I couldn't afford to stop. In Medellín they treated me with the seriousness of an Upper East Side clinic and I flew home walking pain-free."

9. Combine treatment with recovery

Medellín offers a recovery environment that's hard to match: constant temperature, healthy food, medical spas, training with sports physiotherapists, and extension options to Cartagena, the Coffee Region or Guatapé for the active-rest phase. Many patients from New York turn the trip into a 10–14 day mini-retreat.

10. Frequently asked questions from New York

Is this therapy legal? Yes. It's regulated by INVIMA and delivered in centers with an ethics committee.

How long until I see results? Initial improvement in 2–6 weeks; effect consolidates in 3–6 months.

Can I fly back the next day? We prefer 48–72 h after an intra-articular injection.

Does my insurance cover it? Most international insurers don't cover it, but we provide documentation for FSA/HSA reimbursement when applicable.

What if I need a second dose? It's planned from the start; many patients from New York return at 6–12 months for a booster.

About Dr. Joaqui

Dr. William Joaqui is regarded as one of the leading references in regenerative medicine and stem cell therapy in Latin America. He has developed integrated protocols combining mesenchymal stem cells, exosomes, peptides, NAD+ and biomechanical rehab. He personally attends every international patient from the initial teleconsult through post-treatment follow-up.